Key result
ECM-PPY microspheres improve cardiac function and reduce fibrosis in a rat MI model.
Why the study?
Conductive hydrogels hold promise for treating myocardial infarction, but their dense network limits cellular infiltration and angiogenesis, and mechanical mismatch with native heart tissues may provoke arrhythmia.
ECM-PPY conductive microspheres offer a promising bioactive strategy for enhancing myocardial repair and improving cardiac function after myocardial infarction in a preclinical model.
Answers are grounded in this paper and cite their sources.
Requires validation in large-animal models before clinical trials; extends randomized preclinical evidence for conductive biomaterials in post-MI repair.
Conductive hydrogels hold great promise for treating myocardial infarction (MI) by electrically coupling with the myocardium to improve the local microenvironment. However, their dense network often limits cellular infiltration and angiogenesis, while a mechanical mismatch with native heart tissues may provoke arrhythmia. Here, inspired by the biochemical and electrical microenvironment of the myocardium, we fabricated conductive hydrogel microspheres by first modifying a myocardial tissue-derived decellularized extracellular matrix (d-ECM) with methacryloyl groups to yield a photo-cross-linkable ECM hydrogel precursor. We generated uniformly sized ECM microspheres via a cross-shaped PDMS microfluidic chip, which were subsequently endowed with electrical conductivity via in situ oxidative polymerization of polypyrrole (PPY), resulting in ECM-PPY microspheres. In vitro studies demonstrated that ECM-PPY significantly upregulated the connexin 43 (Cx43) expression in cardiomyocytes. Moreover, the conductive microspheres promoted human umbilical vein endothelial cell migration and tube formation. In a rat MI model, treatment with ECM-PPY microspheres improved the cardiac function. Furthermore, the conductive microspheres reduced the fibrotic area, stimulated microvessel formation, increased the level of Cx43 expression, and suppressed cardiomyocyte apoptosis in the infarcted region. These findings demonstrate a conductive and bioactive microsphere-based strategy for myocardial repair after an MI.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied Myocardial infarction (MI). ECM-PPY microspheres was evaluated on Cardiac function, fibrotic area, microvessel formation, Cx43 expression, and cardiomyocyte apoptosis. Treatment with ECM-PPY microspheres improved cardiac function, reduced fibrotic area, stimulated microvessel formation, and suppressed cardiomyocyte apoptosis in a rat myocardial infarction model.
Synapse has enriched 10 related papers. Consider them for comparative context: